HEADER TRANSCRIPTION 30-NOV-08 3FEI
TITLE DESIGN AND BIOLOGICAL EVALUATION OF NOVEL, BALANCED DUAL PPARA/G
TITLE 2 AGONISTS
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: PPARALPHA LIGAND BINDING DOMAIN;
COMPND 5 SYNONYM: PPAR-ALPHA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 1;
COMPND 6 ENGINEERED: YES;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: PEPTIDE MOTIF 5 OF NUCLEAR RECEPTOR COACTIVATOR 1;
COMPND 9 CHAIN: Z;
COMPND 10 SYNONYM: SRC-1 COACTIVATOR PROTEIN MOTIF 5;
COMPND 11 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: PPARA, NR1C1, PPAR;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B;
SOURCE 10 MOL_ID: 2;
SOURCE 11 SYNTHETIC: YES;
SOURCE 12 OTHER_DETAILS: CHEMICALLY SYNTHESIS
KEYWDS NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, DIABETES, ACTIVATOR, DNA-
KEYWDS 2 BINDING, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR,
KEYWDS 3 TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER
EXPDTA X-RAY DIFFRACTION
AUTHOR J.BENZ,U.GRETHER,B.GSELL,A.BINGGELI,H.HILPERT,H.P.MAERKI,P.MOHR,
AUTHOR 2 A.RUF,M.STIHLE,D.SCHLATTER
REVDAT 2 27-DEC-23 3FEI 1 REMARK
REVDAT 1 20-OCT-09 3FEI 0
JRNL AUTH U.GRETHER,A.BENARDEAU,J.BENZ,A.BINGGELI,D.BLUM,H.HILPERT,
JRNL AUTH 2 B.KUHN,H.P.MAERKI,M.MEYER,P.MOHR,K.PUNTENER,S.RAAB,A.RUF,
JRNL AUTH 3 D.SCHLATTER
JRNL TITL DESIGN AND BIOLOGICAL EVALUATION OF NOVEL, BALANCED DUAL
JRNL TITL 2 PPARALPHA/GAMMA AGONISTS
JRNL REF CHEMMEDCHEM V. 4 951 2009
JRNL REFN ISSN 1860-7179
JRNL PMID 19326383
JRNL DOI 10.1002/CMDC.200800425
REMARK 2
REMARK 2 RESOLUTION. 2.40 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.2.0005
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 3 NUMBER OF REFLECTIONS : 12282
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.219
REMARK 3 R VALUE (WORKING SET) : 0.217
REMARK 3 FREE R VALUE : 0.260
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900
REMARK 3 FREE R VALUE TEST SET COUNT : 630
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46
REMARK 3 REFLECTION IN BIN (WORKING SET) : 882
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.25
REMARK 3 BIN R VALUE (WORKING SET) : 0.2810
REMARK 3 BIN FREE R VALUE SET COUNT : 47
REMARK 3 BIN FREE R VALUE : 0.4820
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2043
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 29
REMARK 3 SOLVENT ATOMS : 141
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 54.30
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.92
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.29000
REMARK 3 B22 (A**2) : -4.88000
REMARK 3 B33 (A**2) : 5.17000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.425
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.269
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.225
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.649
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2111 ; 0.010 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2842 ; 1.315 ; 1.992
REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 250 ; 5.185 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 95 ;34.748 ;24.526
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 393 ;15.587 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;23.319 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 323 ; 0.085 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1548 ; 0.004 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1009 ; 0.207 ; 0.200
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1439 ; 0.299 ; 0.200
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 150 ; 0.197 ; 0.200
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 26 ; 0.172 ; 0.200
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.138 ; 0.200
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1316 ; 0.672 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2043 ; 1.187 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 934 ; 1.514 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 799 ; 2.445 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : BABINET MODEL WITH MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 3FEI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 03-DEC-08.
REMARK 100 THE DEPOSITION ID IS D_1000050490.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 01-AUG-02
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 8.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SLS
REMARK 200 BEAMLINE : X06SA
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.91840
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12953
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400
REMARK 200 RESOLUTION RANGE LOW (A) : 30.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.06600
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 25.2000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49
REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.34500
REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.200
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: NULL
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.15
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS, 0.2M MGCL2, 25% PEG3350,
REMARK 280 15% GLYCEROL, PH 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE
REMARK 280 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.26400
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.94550
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.85250
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.94550
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.26400
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.85250
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1130 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 12240 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, Z
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 231
REMARK 465 LYS A 232
REMARK 465 ALA A 233
REMARK 465 SER A 234
REMARK 465 ASN A 235
REMARK 465 ASN A 236
REMARK 465 PRO A 237
REMARK 465 LYS A 252
REMARK 465 THR A 253
REMARK 465 LEU A 254
REMARK 465 VAL A 255
REMARK 465 ALA A 256
REMARK 465 LYS A 257
REMARK 465 LEU A 258
REMARK 465 VAL A 259
REMARK 465 ALA A 260
REMARK 465 ASN A 261
REMARK 465 GLY A 262
REMARK 465 ILE A 263
REMARK 465 GLN A 264
REMARK 465 ASN A 265
REMARK 465 LYS Z 744
REMARK 465 ASP Z 745
REMARK 465 ASP Z 754
REMARK 465 LYS Z 755
REMARK 465 ASP Z 756
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 SG CYS A 352 O HOH A 85 1.90
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ALA A 268 -73.90 -55.38
REMARK 500 ASN A 326 -168.93 -116.74
REMARK 500 ALA A 333 57.50 37.84
REMARK 500 ASP A 453 42.37 -100.30
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CTM A 1
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3FEJ RELATED DB: PDB
DBREF 3FEI A 202 468 UNP Q07869 PPARA_HUMAN 202 468
DBREF 3FEI Z 744 756 UNP Q15788 NCOA1_HUMAN 744 756
SEQRES 1 A 267 ASP LEU LYS SER LEU ALA LYS ARG ILE TYR GLU ALA TYR
SEQRES 2 A 267 LEU LYS ASN PHE ASN MET ASN LYS VAL LYS ALA ARG VAL
SEQRES 3 A 267 ILE LEU SER GLY LYS ALA SER ASN ASN PRO PRO PHE VAL
SEQRES 4 A 267 ILE HIS ASP MET GLU THR LEU CYS MET ALA GLU LYS THR
SEQRES 5 A 267 LEU VAL ALA LYS LEU VAL ALA ASN GLY ILE GLN ASN LYS
SEQRES 6 A 267 GLU ALA GLU VAL ARG ILE PHE HIS CYS CYS GLN CYS THR
SEQRES 7 A 267 SER VAL GLU THR VAL THR GLU LEU THR GLU PHE ALA LYS
SEQRES 8 A 267 ALA ILE PRO GLY PHE ALA ASN LEU ASP LEU ASN ASP GLN
SEQRES 9 A 267 VAL THR LEU LEU LYS TYR GLY VAL TYR GLU ALA ILE PHE
SEQRES 10 A 267 ALA MET LEU SER SER VAL MET ASN LYS ASP GLY MET LEU
SEQRES 11 A 267 VAL ALA TYR GLY ASN GLY PHE ILE THR ARG GLU PHE LEU
SEQRES 12 A 267 LYS SER LEU ARG LYS PRO PHE CYS ASP ILE MET GLU PRO
SEQRES 13 A 267 LYS PHE ASP PHE ALA MET LYS PHE ASN ALA LEU GLU LEU
SEQRES 14 A 267 ASP ASP SER ASP ILE SER LEU PHE VAL ALA ALA ILE ILE
SEQRES 15 A 267 CYS CYS GLY ASP ARG PRO GLY LEU LEU ASN VAL GLY HIS
SEQRES 16 A 267 ILE GLU LYS MET GLN GLU GLY ILE VAL HIS VAL LEU ARG
SEQRES 17 A 267 LEU HIS LEU GLN SER ASN HIS PRO ASP ASP ILE PHE LEU
SEQRES 18 A 267 PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU ARG GLN
SEQRES 19 A 267 LEU VAL THR GLU HIS ALA GLN LEU VAL GLN ILE ILE LYS
SEQRES 20 A 267 LYS THR GLU SER ASP ALA ALA LEU HIS PRO LEU LEU GLN
SEQRES 21 A 267 GLU ILE TYR ARG ASP MET TYR
SEQRES 1 Z 13 LYS ASP HIS GLN LEU LEU ARG TYR LEU LEU ASP LYS ASP
HET CTM A 1 29
HETNAM CTM (2S)-3-(4-{[2-(4-CHLOROPHENYL)-1,3-THIAZOL-4-
HETNAM 2 CTM YL]METHOXY}-2-METHYLPHENYL)-2-ETHOXYPROPANOIC ACID
HETSYN CTM 3-{4-[2-(4-CHLORO-PHENYL)-THIAZOL-4-YLMETHOXY]-2-
HETSYN 2 CTM METHYL-PHENYL}-2-(S)-ETHOXY-PROPIONIC ACID
FORMUL 3 CTM C22 H22 CL N O4 S
FORMUL 4 HOH *141(H2 O)
HELIX 1 1 SER A 205 PHE A 218 1 14
HELIX 2 2 ASN A 221 SER A 230 1 10
HELIX 3 3 ASP A 243 GLU A 251 1 9
HELIX 4 4 GLU A 267 ALA A 293 1 27
HELIX 5 5 ASP A 301 SER A 322 1 22
HELIX 6 6 SER A 323 MET A 325 5 3
HELIX 7 7 ALA A 333 GLY A 335 5 3
HELIX 8 8 ARG A 341 SER A 346 1 6
HELIX 9 9 PRO A 350 ILE A 354 5 5
HELIX 10 10 MET A 355 ALA A 367 1 13
HELIX 11 11 ASP A 371 CYS A 384 1 14
HELIX 12 12 ASN A 393 HIS A 416 1 24
HELIX 13 13 PHE A 421 GLU A 451 1 31
HELIX 14 14 HIS A 457 ARG A 465 1 9
HELIX 15 15 HIS Z 746 LEU Z 753 1 8
SHEET 1 A 3 PHE A 239 ILE A 241 0
SHEET 2 A 3 GLY A 337 THR A 340 1 O PHE A 338 N ILE A 241
SHEET 3 A 3 GLY A 329 VAL A 332 -1 N MET A 330 O ILE A 339
CISPEP 1 LYS A 349 PRO A 350 0 3.99
SITE 1 AC1 11 PHE A 273 CYS A 276 SER A 280 TYR A 314
SITE 2 AC1 11 PHE A 318 MET A 330 VAL A 332 MET A 355
SITE 3 AC1 11 HIS A 440 LEU A 460 TYR A 464
CRYST1 42.528 75.705 97.891 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.023514 0.000000 0.000000 0.00000
SCALE2 0.000000 0.013209 0.000000 0.00000
SCALE3 0.000000 0.000000 0.010215 0.00000